4SU-23047-09129
3 vaccinations
7 coded responses
42 check-ins
7 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 750 / TX
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 1 — Moderna
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
-
2021-03-01
Dose 2 — Moderna
-
2021-03-01
Survey response — day 0, dose 2MedDRA: Upper-airway cough syndrome — Feeling: Good · FeverFree text: Post nasal secretionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Nasal secretionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-05-31
- 2021-08-30
-
2021-10-27
Dose 3 — Moderna
- 2021-10-27
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Chills, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
-
2021-11-11
Survey response — day 14, dose 3MedDRA: Blood bilirubin increased, Faeces pale, Flatulence, Hepatic enzyme increased, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Symptoms: Flatulence Increase bilirrubina light stools and increase liver enzymes · Healthcare visit (other): Endoscopy US and stentMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Report sent to call center — day 14, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · no matching call case
- 2021-11-17
- 2021-11-24
-
2021-12-01
Survey response — day 35, dose 3MedDRA: Abdominal pain, Pre-existing disease, Vomiting — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Abdominal pain and vomits do as pancreatitis autoimmuneMedDRA releases: 2024-11 · check-in free text available
- 2021-12-08
-
2022-01-26
Survey response — 3 months, dose 3MedDRA: Autoimmune pancreatitis, Emergency care — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Symptoms: I developed autoinmune pancreatitis following 5days after the Moderna booster · Healthcare visit (other): Emergency ERCPMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-01-27
-
2022-01-27
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-27
Survey response — 6 months, dose 3MedDRA: Pancreatitis, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Flares of autoimmune pancreatitisMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-29
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-10-27
Survey response — 12 months, dose 3MedDRA: Autoimmune pancreatitis, Gastrointestinal disorder — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: I had developed autoimmune pancreatitis with use of azathioprine for one year and continue with episodic abdominal symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-28
Call successfulReported to VAERS voluntarily prior to GDIT contact
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Moderna | |
| 2 | 2021-03-01 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 2
1 check-in flagged for a call with no call center case on record
Free text
Release 4 — day 0, dose 2
Systemic reaction (other): Post nasal secretions
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Nasal secretions
Release 10 — day 14, dose 3
Symptoms: Flatulence Increase bilirrubina light stools and increase liver enzymes
Healthcare visit (other): Endoscopy US and stent
Release 10 — day 35, dose 3
Symptoms: Abdominal pain and vomits do as pancreatitis autoimmune
Release 11 — 3 months, dose 3
Symptoms: I developed autoinmune pancreatitis following 5days after the Moderna booster
Healthcare visit (other): Emergency ERCP
Release 11 — 6 months, dose 3
Symptoms: Flares of autoimmune pancreatitis
Release 12 — 12 months, dose 3
Symptoms: I had developed autoimmune pancreatitis with use of azathioprine for one year and continue with episodic abdominal symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal pain | · | · | ✓ |
| SD | Autoimmune pancreatitis | · | · | ✓ |
| SD | Blood bilirubin increased | · | · | ✓ |
| SD | Faeces pale | · | · | ✓ |
| SD | Flatulence | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Hepatic enzyme increased | · | · | ✓ |
| SD | Pancreatitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release